# A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

Source: https://onco.cc/trials/nct06797986/  
OnCo record `nct06797986` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of BVAC-E6E7 (low level) in head and neck squamous cell carcinoma, run by Cellid Co., Ltd., now recruiting.

## Summary

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. is a phase 1/2 interventional study registered as NCT06797986 by Cellid Co., Ltd., with 37 participants planned, started 2026-02-04 and due to reach its primary completion in 2027-03. Interventions recorded: BVAC-E6E7 (low level), BVAC-E6E7 (high level) and BVAC-E6E7 (RP2D).

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06797986
- Phase: 1/2
- Setting: A Phase I/IIa Clinical Trial to Investigate the Safety, Immunogenicity and Efficacy of BVAC-E6E7 in Subjects With HPV Type 16 and/or 18 Positive Unresectable Recurrent or Metastatic Head
- Sponsor: Cellid Co., Ltd.
- Enrolled: 37

## Sources

- ClinicalTrials.gov NCT06797986: https://clinicaltrials.gov/study/NCT06797986

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/)

---
JSON: https://onco.cc/api/v1/entities/nct06797986.json